#1signifyhealth. Barclays Healthcare Conference March 15, 2022 -> Homeward.#2→Forward looking statements This presentation contains forward-looking statements. All statements other than statements of historical fact included in this presentation are forward-looking statements. These statements may be preceded by, followed by or include the words "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business, our plan to drive better patient outcomes, our 2022 Outlook, including our 2022 estimates for total GAAP revenue, total Adjusted EBITDA, in-home evaluations, bundled payment program size and bundled payment weighted average savings rate improvements. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include: our failure to maintain and grow our network of high-quality network providers; the COVID-19 pandemic and whether the pandemic will continue to subside in 2022; factors beyond our control that could impact our ability to complete IHES; our dependence upon a limited number of key customers; our dependence on certain key government programs including BPCI-A; risks associated with estimating program size and savings rate in BPCI-A; ; our failure to continue to innovate and provide services that are useful to customers and achieve and maintain market acceptance; our limited operating history with certain of our solutions; our failure to compete effectively; the length and unpredictability of our sales cycle; seasonality that may cause fluctuations in our sales, cash flows and results of operations; the information we provide to, or receive from, our health plans and providers could be inaccurate or incomplete; the risk that the cost of services provided will be higher than benchmark prices in our episodes and care redesign solutions; risks that arise from operating internationally; failure of our existing customers to continue or renew their contracts with us; failure of service providers to meet their obligations to us; ; our failure to achieve or maintain profitability; our revenue not growing at the rates they historically have, or at all; our failure to successfully execute on our growth initiatives, business strategies, or operating plans, including growth in our Commercial Episodes business; our failure to successfully launch new products; our failure to diversify sources of revenues and earnings; inaccurate estimates and assumptions used to determine the size of our total addressable market; changes in accounting principles applicable to us; incorrect estimates or judgments relating to our critical accounting policies; increases in our level of indebtedness; our failure to effectively adapt to changes in the health care industry, including changes in the rules governing Medicare or other federal health care programs; our failure to adhere to complex and evolving governmental laws and regulations; our failure to comply with current and future federal and state privacy, security and data protection laws, regulations or standards; our employment of and contractual relationships with our providers subjecting us to licensing or other regulatory risks, including recharacterization of our contracted providers as employees; adverse findings from inspections, reviews, audits and investigations from health plans; inadequate investment in or maintenance of our operating platform and other information technology and business systems; our ability to develop and/or enhance information technology systems and platforms to meet our changing customer needs; higher than expected investments in our business including, but not limited to, investments in signifyhealth. our technology and operating platform, which could reduce our profitability; security breaches or incidents, loss or misuse of data, a failure in or breach of our operational or security systems or other disruptions; disruptions in our disaster recovery systems or management continuity planning; our ability to comply with, and changes to, laws, regulations and standards relating to privacy or data protection; our ability to obtain, maintain, protect and enforce our intellectual property; our dependence on distributions from Cure Top Co, LLC to fund dividend payments, if any, and to pay our taxes and expenses, including payments under the Tax Receivable Agreement; the control certain equity holders that held an ownership interest in Cure TopCo, LLC prior to our IPO have over us and our status as a controlled company; our ability to realize any benefit from our organizational structure; and the other risk factors described under "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which are available free of charge on the SEC's website at: www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements. In addition, all forward-looking statements speak only as of the date of this press release. We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise other than as required under the federal securities laws. This presentation contains certain financial measures not presented in accordance with generally accepted accounting principles in the United State ("GAAP"), including Adjusted EBITDA, which is used by management in making operating decisions, allocating financial resources, and internal planning and forecasting and for business strategy purposes. Adjusted EBITDA is not a measure of financial performance in accordance with GAAP and may exclude items that are significant in understanding and assessing our financial results. Therefore, this mea should not be considered in isolation or as an alternative to GAAP measures. Our presentation of Adjusted EBITDA may not be comparable to similarly-titled measures used by other companies. Management believes that such measures are commonly reported by issuers and widely used by investors as indicators of a company's operating performance. There are other non-GAAP financial measures which should be considered only as a supplement to, and not as a superior measure to, financial measures prepared in accordance with GAAP. Please refer to the Appendix of this document for a reconciliation of Adjusted EBITDA to the most directly comparable financial measure prepared in accordance with GAAP. This presentation includes market and industry data and forecasts that we have derived from independent consultant reports, publicly available information, various industry publications, other published industry sources, and our internal data and estimates. Independent consultant reports, industry publications, and other published industry sources generally indicate that the information contained therein was obtained from sources believed to be reliable. The inclusion of market estimations, rankings, and industry data in this presentation is based upon such reports, publications, and other sources and our internal data and estimates and our understanding of industry conditions. Although we believe that such information is reliable, we have not had this information verified by any independent sources. You are cautioned not to give undue weight to such estimates. All trademarks, service marks, and trade names appearing in this presentation are the property of their respective holders. 2#3--> National leader in value-based care 1) 2) signifyhealth. Driving the shift to value- based care and enabling more healthy, happy days at home NYSE: SGFY Includes Caravan and Signify proforma combined spend for 2021 As of, or for the year ended 12/31/2021 signifyhealth. Managing clinical, social, and behavioral health needs for people in every county through provider $10B (¹) 700+ (2) networks, technology and analytics. healthcare spend managed in 2021 health systems & provider groups 1.9M 600+ (²) homes visited in 2021 clinical & social care coordinators 10K (²) 10% +(2) providers in network reduced hospital readmissions 3#4→Advancing our mission. Enabling more healthy, happy days at home for the people we serve HOME • Do more in and around the home to engage consumers in their health VALUE • Enable more risk-taking, analytical insights, and success in value-based payment arrangements CARE ● Integrate clinical and social care for a more holistic patient experience signifyhealth. | A#5→> Caravan Health is now part of Signify Health End-to-end capabilities support the full continuum signifyhealth + 1) ● ● ● ● Leading convener and enabler of Episodes / Bundles Depth with health systems, hospitals and PGPs Strength in care redesign Strength in Post Acute Management and Transitions of Care homeward Ability to engage patients in the home at scale with both clinical and social care Includes Caravan and Signify combined proforma spend for 2021 signifyhealth. CARAVANHEALTH. Shared vision to transform how care is paid for and delivered Massive combined network of partners in VBC arrangements $10B (1) spend under management 200+ provider organizations in ACOS 6 collaborative ACOS End-to-end VBC platform (BPCIA, MSSP, Commercial Episodes & ACO; Medicare FFS, MA, and Commercial) Primed to expand with payers and new models (Commercial, ACO REACH) ● ● ● ● Leading convener and enabler of Collaborative ACOS Depth with rural providers and community health systems Strength in practice transformation and population health initiatives Expertise and growth in enabling providers in 340B 5#6-> Propelling the rise of value-based programs Driving success across all Value-based programs Medicare Advantage (MA) Managed Medicaid BPCI-A Episodes (Bundled Payment for Care Improvement - Advanced Model) signifyhealth. ACO (Accountable Care Organizations) Commercial Episodes (Bundled Payment for Payors & Employers) Our mission Transform how care is paid for and delivered so that people can enjoy more healthy, happy days at home signifyhealth Our vision To build a healthier place for us all to live and age in Long-term relationships with payors, providers and employers. Humana. STATE OF CONNE CONTR Advent Health OPTUM™ CENTENE EmblemHealth COMPTROLLER Ascension PURGEONS Anthem. Geisinger ORLANDO MEMORIAL HERMANN HEALTH 5 SENTAR AⓇ WellCare Regence Proliance UHS Intermountain Healthcare Independence aetna CAMBIA CALT SOLUTION oscar Leveraging our multi-payor contracts to create more relevancy for providers Beaumont PriorityHealth HCSC Health Care Service Corporation BAPTIST HEALTH ST. JOSEPH Regional Medical Center 6#7→> Homeward: broad and expanding product portfolio -> Helping individuals stay healthy & independent at home Home & Community Services In-home evaluative signifyhealth. services ● 0 0 0 Healthy days at home Diagnostic & preventative services Program data based on one year post launch; performance data based on 7 months post launch. ● ● ● Manage individuals in an episode & drive recovery home Episodes of Care Services Episodes of care services Clinical & social care coordination Customized Clinical & Social Care Coordination programs can be deployed across key offerings ● ● ● ● Post-acute mgmt. services ●000 Our Transition to Home program, a key synergy between HCS & ECS, is live in 68 clients across 15 states yielding low double digit reduction in readmissions to-date for TTH patients. 7#8--> Signify Health's partner program 10K+ providers across the U.S. Behavioral health Quartet signifyhealth. Member engagement Population Health Leveraging our networks & people... 3K+ value based provider sites to expand solutions across our product portfolio referwell 8 €0 600+ clinical & social care coordinators Remote patient monitoring Center Health Distribution channels to employers HealthComp 200 community-based organizations Care optimization MEDALOGIX Center Health + S Social determinants of health 8#9Our platform creates a flywheel effect that drives improvement and growth ● ● ● ● ● ● Extensive capture beyond traditional data sets into the home and community Real-time data from providers, payors, and CMS Reduce unnecessary facility time More healthy days at home Better consumer experience Shared program savings signifyhealth. Appropriate payment for risk assumed 1 Capture data Improve outcomes 4 2 Generate insights Deliver actions 3 ● ● ● ● Risk stratification and predictive modeling Targeted consumer engagement Site-of-care optimization Incentive alignment Access and coordination across care continuum: ambulatory, acute, post-acute and the home Holistic care model: clinical, social, and behavioral 9#10--> Analytics, networks, and technology combine to power and create value-based programs Algorithms powering insights on 40M members in our data chassis (1) signifyhealth & Data capture & analytical insights Networks driving 8 8 holistic Care signifyhealth. Technology- enabled actions 1) As of, or for the year ended 12/31/2021 Decision support pathways 10K(1) physicians & nurses deployable to all 50 states >200(¹) community- based organizations Network Enablement Smart applications Device hub 8 boog Logistics & routing Savings opportunity analyses Consumer Engagement 8 >3,000 (1) value-based provider sites Outreach >600(1) engagement, clinical & social care coordinators Segmentation Coordination Episodes of Care Programs Optimization Pricing & payment Sharing in risk Prevent adverse events ✓Manage conditions holistically ✓ Align payment incentives Healthy days at home 10 -#11-> Expanding platform into novel value-based episodes of care Program Enablement Long-standing experience as a leading enablement platform for programs driving value-based payment innovation Buh signifyhealth. Supporting value-based programs In-Home Evaluations, Clinical & Social Care Coordination ● Health plans in Medicare Advantage and Managed Medicaid Humana. CENTENE Corporation aetna CAMBIA HEALTH SOLUTIONS OPTUM -> Program Creation Leveraging our established infrastructure to launch novel program arrangements in commercial market Partnering in value-based programs Episode Bundled Payments • Health system and provider ● group partner network in BPCI and BPCI-A A Ascension UHS Advent Health Geisinger Beaumont Intermountain Healthcare Designing value-based programs Expanded Program Innovation in Commercial Market ● Novel commercial episode programs for payors employers, covering procedural and chronic conditions STATE OF CONNECTICUT NUA COMPTROLLER CAMBIA HEALTH SOLUTIONS superior healthplan 11 -#12→> Large addressable market with strong tailwinds Enrollment in Addressable Programs Value-based Spend Members enrolled in Medicare Advantage and Medicaid Managed Care Signify IHE's conducted in 2021 84 million (1) signifyhealth. 1.9 million 1) Reflects 2021 Medicare Advantage enrollment per CMS and 2021 Medicaid Managed care enrollment per KFF 2) Health Care Payment Learning & Action Network 2020/2021 Methodology and Results Report 3) Including Caravan, 2021 spend under management on a proform a basis was $10 billion -$400 billion (2) -$200 billion (2) $4.6 billion Spend under value-based care in government and private / commercial lines of business Spend under value-based care alternative payment models with downside risk Signify 2021 episode spend under management (3) -75% of healthcare payments expected to be tied to value- based care by 2025 (2) 10 - 1 6 • 0 12#13→ Attractive financial model, growth, and profitability -> $502 2019 signifyhealth. Revenue ($ in millions) CAGR: 24%(2) $611 2020 $773 2021 $948-971E 2022 Guidance 1) See Appendix for "Reconciliation from GAAP net loss to Adjusted EBITDA" for a reconciliation of Adjusted EBITDA to net loss and the calculation of Adjusted EBITDA Margin 2) Reflects mid-point of 2022 guidance range. 2022 guidance includes Caravan for 10 months. $93 2019 Adjusted EBITDA(¹) ($ in millions) CAGR: 33% (2) $125 2020 $171 2021 $212-222E 2022 Guidance 13#14--> National leader in value-based care 1) 2) signifyhealth. Driving the shift to value- based care and enabling more healthy, happy days at home NYSE: SGFY Includes Caravan and Signify combined proforma spend for 2021 As of, or for the year ended 12/31/2021 signifyhealth. Managing clinical, social, and behavioral health needs for people in every county through provider $10B (¹) 700+ (2) networks, technology and analytics. healthcare spend managed in 2021 health systems & provider groups 1.9M 600+ (²) homes visited in 2021 clinical & social care coordinators 10K (²) 10% +(2) providers in network reduced hospital readmissions 14#15Appendix signifyhealth. 15 —#16->Reconciliation from GAAP Net Loss to Adjusted EBITDA $ in millions Net income (loss) Interest expense Loss on extinguishment of debt Income tax expense Depreciation and amortization signifyhealth. Other expense (income), net Asset impairment Equity-based compensation Customer equity appreciation rights Transaction-related expenses SEU expense Other (2) Adjusted EBITDA Adjusted EBITDA Margin 2021 9.9 21.7 5.0 4.2 70.7 2.8 11.2 12.9 19.7 9.9 1.7 1.5 171.2 22.1% Year Ended December 31 2020 (14.5) 22.2 0.9 62.3 9.0 0.8 12.1 12.4 15.2 4.5 124.9 20.5% 20191 (28.5) 21.2 -- 0.1 66.0 (1.6) 6.4 4.5 ! 22.4 2.8 93.3 18.6% 1) Remedy Partners acquisition completed on 1/15/2019. 2) Other includes remeasurement of contingent consideration, non-recurring expenses, including those associated with one-time costs related to the COVID-19 pandemic, the closure of certain facilities, the sale of certain assets and the early termination of certain contracts. 16